66 related articles for article (PubMed ID: 20955376)
1. Comparison of cytology and histology results in English cervical screening laboratories before and after liquid-based cytology conversion: do the data provide evidence for a single category of high-grade dyskaryosis?
Blanks RG; Kelly RS
Cytopathology; 2010 Dec; 21(6):368-73. PubMed ID: 20955376
[TBL] [Abstract][Full Text] [Related]
2. Using a graph of the abnormal predictive value versus the positive predictive value for the determination of outlier laboratories in the National Health Service cervical screening programme.
Blanks RG
Cytopathology; 2010 Dec; 21(6):379-88. PubMed ID: 20518798
[TBL] [Abstract][Full Text] [Related]
3. Borderline nuclear change, high-grade dyskaryosis not excluded: current concepts and impact on clinical practice.
Hoo SS; Patel A; Buist H; Galaal K; Hemming JD; Naik R
Cytopathology; 2012 Dec; 23(6):396-401. PubMed ID: 22136410
[TBL] [Abstract][Full Text] [Related]
4. An audit of liquid-based cervical cytology screening samples (ThinPrep and SurePath) reported as glandular neoplasia.
Thiryayi SA; Marshall J; Rana DN
Cytopathology; 2010 Aug; 21(4):223-8. PubMed ID: 19843139
[TBL] [Abstract][Full Text] [Related]
5. The Positive Predictive Value of High-Grade Squamous Intraepithelial Lesion on Cytology for the Histological Diagnosis of Cervical Intraepithelial Neoplasia 2 or Higher: A Systematic Review.
Karia N; Van Loon A; Simoens C; Benoy I; Bogers J
Acta Cytol; 2019; 63(3):206-214. PubMed ID: 30947186
[TBL] [Abstract][Full Text] [Related]
6. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
7. Management of women with abnormal cervical cytology: treatment patterns and associated costs in England and Wales.
Martin-Hirsch P; Rash B; Martin A; Standaert B
BJOG; 2007 Apr; 114(4):408-15. PubMed ID: 17378815
[TBL] [Abstract][Full Text] [Related]
8. The role of cervical cytology and colposcopy in detecting cervical glandular neoplasia.
Ullal A; Roberts M; Bulmer JN; Mathers ME; Wadehra V
Cytopathology; 2009 Dec; 20(6):359-66. PubMed ID: 18557985
[TBL] [Abstract][Full Text] [Related]
9. Comparison of SurePath® and ThinPrep® liquid-based cervical cytology using positive predictive value, atypical predictive value and total predictive value as performance indicators.
Wright PK; Marshall J; Desai M
Cytopathology; 2010 Dec; 21(6):374-8. PubMed ID: 20545727
[TBL] [Abstract][Full Text] [Related]
10. Bland dyskaryosis: a new pitfall in liquid-based cytology.
Denton K; Rana DN; Lynch MA; Desai MS
Cytopathology; 2008 Jun; 19(3):162-6. PubMed ID: 18177415
[TBL] [Abstract][Full Text] [Related]
11. Proposed Sheffield quantitative criteria in cervical cytology to assist the diagnosis and grading of squamous intra-epithelial lesions, as some Bethesda system definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):168-78. PubMed ID: 16048503
[TBL] [Abstract][Full Text] [Related]
12. Proposed Sheffield quantitative criteria in cervical cytology to assist the grading of squamous cell dyskaryosis, as the British Society for Clinical Cytology definitions require amendment.
Slater DN; Rice S; Stewart R; Melling SE; Hewer EM; Smith JH
Cytopathology; 2005 Aug; 16(4):179-92. PubMed ID: 16048504
[TBL] [Abstract][Full Text] [Related]
13. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
14. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
[TBL] [Abstract][Full Text] [Related]
15. Transformation zone sampling rate is a useful performance indicator for practitioners collecting cervical samples using SurePath liquid-based cytology system.
Narine N; Young W
Cytopathology; 2007 Aug; 18(4):220-4. PubMed ID: 17578516
[TBL] [Abstract][Full Text] [Related]
16. ABC3 Part II: a review of the new criteria for evaluating cervical cytology in England.
Blanks RG
Cytopathology; 2012 Dec; 23(6):360-70. PubMed ID: 23173805
[TBL] [Abstract][Full Text] [Related]
17. Liquid-based cytology and conventional smears compared over two 12-month periods.
Williams AR
Cytopathology; 2006 Apr; 17(2):82-5. PubMed ID: 16548992
[TBL] [Abstract][Full Text] [Related]
18. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.
Castanon A; Ferryman S; Patnick J; Sasieni P
Cytopathology; 2012 Feb; 23(1):13-22. PubMed ID: 22243289
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing conventional cytology to liquid-based cytology and computer assistance.
Klug SJ; Neis KJ; Harlfinger W; Malter A; König J; Spieth S; Brinkmann-Smetanay F; Kommoss F; Weyer V; Ikenberg H
Int J Cancer; 2013 Jun; 132(12):2849-57. PubMed ID: 23175270
[TBL] [Abstract][Full Text] [Related]
20. The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer.
Yokoyama Y; Futagami M; Watanabe J; Sakuraba A; Nagasawa K; Maruyama H; Sato S
Hum Cell; 2016 Apr; 29(2):83-90. PubMed ID: 26739336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
